| JXSS2000025 | 人血白蛋白 | human albumin | Injection | Biological Products | Import Drug Application | 2020-07-04 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | Certificate Issued | 2021-11-16 | view |
| JXSS2000022 | 人血白蛋白 | human albumin | Injection | Biological Products | Import Drug Application | 2020-07-08 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | Certificate Issued | 2021-11-16 | view |
| JXSS1900051 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2019-08-17 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | Certificate Issued | 2021-08-11 | view |
| JXSS1900052 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2019-08-16 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | Certificate Issued | 2021-08-11 | view |
| JXHL2100112 | 注射用阿帕拉格鲁肽 | | Lyophilized | Chemical Drugs(1) | Import Drug Application | 2021-04-02 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | In Review | 2021-04-02 | view |
| JXHL2100083 | Xevinapant口服溶液 | xevinapant | Oral solution | Chemical Drugs(1) | Import Drug Application | 2021-03-10 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | In Review | 2021-03-10 | view |
| JYSB2100064 | 细菌溶解产物胶囊 | Bacterial Lysates | Capsule | Biological Products | Supplementary Application | 2021-03-05 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | In Review | 2021-03-05 | view |
| JYSB2100065 | 细菌溶解产物胶囊 | Bacterial Lysates | Capsule | Biological Products | Supplementary Application | 2021-03-05 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | In Review | 2021-03-05 | view |
| JYHB2100156 | 咪喹莫特乳膏 | imiquimod | Cream | Chemical Drugs | Supplementary Application | 2021-02-23 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | In Review | 2021-02-22 | view |
| JYSB2000628 | 细菌溶解产物胶囊 | Bacterial Lysates | Capsule | Biological Products | Supplementary Application | 2020-12-18 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | Filed | 2020-12-29 | view |
| JYSB2000626 | 细菌溶解产物胶囊 | Bacterial Lysates | Capsule | Biological Products | Supplementary Application | 2020-12-18 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | Filed | 2020-12-29 | view |
| JYHB2002605 | 咪喹莫特乳膏 | imiquimod | Cream | Chemical Drugs | Supplementary Application | 2020-12-18 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | Filed | 2020-12-29 | view |
| JYHB2002068 | 盐酸贝凡洛尔片 | bevantolol hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-10-19 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | Filed | 2020-11-02 | view |
| JXSS2000042 | Inebilizumab注射液 | inebilizumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-10-14 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | In Review | 2020-10-12 | view |
| JXSS2000043 | Inebilizumab注射液 | inebilizumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-10-14 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | In Review | 2020-10-12 | view |
| JYHB2000655 | 盐酸贝凡洛尔片 | bevantolol hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-06-05 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | Certificate Issued | 2020-07-06 | view |
| JYHB2001170 | 咪喹莫特乳膏 | imiquimod | Cream | Chemical Drugs(5.1) | Supplementary Application | 2020-06-30 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | Filed | 2020-07-02 | view |
| JYHF2000068 | 盐酸贝凡洛尔片 | bevantolol hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-06-04 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | Certificate Issued | 2020-06-23 | view |
| JYHZ1800181 | 咪喹莫特乳膏 | imiquimod | Cream | Chemical Drugs(5.1) | License Renew | 2018-06-28 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | Certificate Issued | 2020-01-17 | view |
| JYHB1901426 | Ataluren口服混悬液颗粒 | ataluren | Granule | Chemical Drugs(5.1) | Supplementary Application | 2019-12-05 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | In Review | 2019-12-04 | view |
